-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Ganoderic acid B
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/81907-61-1.gif)
| Category | HIV Protease |
| CAS | 81907-61-1 |
| Description | Ganoderic acid B (GAB) possesses various pharmaceutical effects and has been used as a chemical marker in quality control of G. lucidum and related products |
Product Information
| Synonyms | (2R,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-heptanoic acid |
| Molecular Weight | 516.67 |
| Molecular Formula | C30H44O7 |
| Canonical SMILES | CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C |
| Boiling Point | 689.0±55.0 °C at 760 mmHg |
| Flash Point | 384.4±28.0 °C |
| Purity | >98% |
| Density | 1.2±0.1 g/cm3 |
| Solubility | In Vitro: DMSO : 50 mg/mL(96.77 mM;Need ultrasonic) |
| Appearance | Powder |
| Storage | 4°C, protect from light * In solvent : -80°C, 6 months -20°C, 1 month (protect from light) |
| Complexity | 1070 |
| Exact Mass | 516.30870374 |
| Index Of Refraction | 1.565 |
| PSA | 128.97000 |
| Target | HIV Protease |
| Vapor Pressure | 0.0±4.9 mmHg at 25°C |
| XLogP3-AA | 2.2 |
